IBM acquires data analytics software provider Envizi

  • IBM (NYSE: IBM ) has acquired data analytics software provider Envizi for an undisclosed amount.
  • Envizi specializes in data and analytics software for sustainability and energy. IBM already implements Envizi to help streamline tracking and reporting of its progress against the company's own goals in renewable electricity procurement and greenhouse gas (GHG) emissions reduction.
  • Envizi will integrate with IBM Maximo asset management solutions, IBM Sterling supply chain solutions, IBM Environmental Intelligence Suite and IBM Turbonomic and Red Hat OpenShift capabilities, enabling companies to automate the feedback generated between their corporate environmental initiatives and the operational endpoints being used in daily business operations.
  • Last week, it was reported that IBM was looking to sell its Watson Health unit for more than $1B.

    Over the current book year the total revenu from the company based in Armonk will be 60.74 billion USD (consensus estimates). This is slightly more than 2021's revenue of 57.35 billion USD.

    Historical revenues and results IBM plus estimates 2021

    historische koersen

    The analysts expect for 2021 a net profit of 8.95 billion USD. For this year the consensus of the result per share is a profit of 9.9 USD. The price/earnings-ratio therefore equals 12.62.

    Huge dividend IBM

    Per share the analysts expect a dividend of 6.78 USD per share. Thus the dividend yield equals 5.43 percent. The average dividend yield of the IT-companies equals an attractive2.75 percent.

    Newest target prices around 129 USD

    The most recent recommendations for the IT-company are from KBC Securities, Independent Research and A.G. Edwards.

    IBM 's market capitalization is based on the number of outstanding shares around 111.55 billion USD. 14

    At 15.58 the stock trades 0.17 percent lower at 124.97 USD.

    Historical stock prices IBM past 10 years

    financial analysis ibm News Wire & Equity Research: +31 084-0032-842

    Copyright B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.